Please login to the form below
cardiology
This page shows the latest cardiology news and features for those working in and with pharma, biotech and healthcare.
Bayer takes control of BlueRock stem cell joint venture
various diseases in the neurology, cardiology and immunology categories.
Latest news
-
Blow for Entresto in latest heart failure trial
Novartis will present new data on cardiac remodeling at the European Society of Cardiology (ESC) congress 2019, and more detailed resilts from the Paragon-HF trial will also be reported at
-
Novartis raises 2019 guidance as new products gather speed
line use in hospitalised patients by a European cardiology association in May.
-
Mistrust of pharma still blocking NHS collaborations
As a result, outpatient cardiology clinics were less busy and post-discharge waiting times fell by over 50%.
-
Real-world data finds patients feel better on Entresto, says Novartis
The real-world data - reported at the European Society of Cardiology Heart Failure (ESC-HF) Congress over the weekend - comes from the CHAMP-HF registry of heart failure patients and specifically ... According to CHAMP-HF Chair Gregg Fonarow of UCLA's
-
Sanofi, Regeneron offer price cut for cholesterol drug Praluent
The offer has been made just after the presentation of the large-scale ODYSSEY OUTCOMES at the American College of Cardiology (ACC) meeting in Orlando, which showed that adding PCSK9 inhibitor
More from news
Approximately 8 fully matching, plus 144 partially matching documents found.
Latest Intelligence
-
How can pharma build bridges with HCPs online?
The programme was targeted to HCPs in haematology, cardiology, geriatrics and elderly care audiences in ten key regions.
-
Here’s to all the bright sparks
The next year, in 1950, John Hopps turned the world of cardiology upside down when he invented the pacemaker.
-
The hitchhiker’s guide to the millennial healthcare professional
and social channels to direct them to robust clinical information before eventually starting up his own repository for cardiology information.
-
Medical affairs - the time for change is now
An example for such solutions is the 'Stent for life' initiative: initiated by European cardiology societies, 'Stent for life' brings interventional cardiologists, government representatives, patient groups as well as industry partners ... Twenty
-
Is it possible to change behaviour virtually?
What value did the virtual mannequin add? . It was the first time ever a virtual mannequin had been used at the European Society of Cardiology (ESC) congress - attracting a lot of
More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest appointments
-
emotive bolsters client services team
During her six years at Chameleon, she was responsible for medical communications acitivites in various therapy areas including diabetes, cardiology, immunology, gastroenterology and rare diseases.
-
Axon bolsters team with new PR Director hire
During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.
-
Former Novartis vaccines CMO joins Arterial
board. Dr Weissback brings over 25 years of life science industry experience to the post - with particular expertise in cardiology, infectious diseases and oncology - and is currently chief operating officer at
-
MyoKardia appoints COO and medical affairs VP
Dr Lee (pictured right) joins the cardiology specialist from the University of California, San Francisco (UCSF), where she was director of the therapeutics and digital health technologies accelerator programme, Catalyst, at
-
Arquer Diagnostics appoints CEO
Previously, she has served as chief executive of Alium Medical, a UK-based global supply service, managing director of medical devices, EMEA at Allergan, and marketing director for interventional cardiology, EMEA
More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Conference research case study
Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress.
-
Bringing the NHS into the 21st century
We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.
-
NOAC Education: Empowering Stroke Prevention
Prominent faculty. Our faculty of international experts in the field of cardiology brings confidence and clarity across all of the topics covered, condensing the wealth of real-world data into concise,
-
Radcliffe Cardiology
Radcliffe Cardiology is an innovative media and publishing company that aims to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration ... Radcliffe Cardiology.
-
Medical Media Communications
MMC Scientific is the dedicated medical communications agency of The Radcliffe Group Ltd, affiliated to Radcliffe Cardiology, granting access to its global database of 65, 000+ cardiologists worldwide.
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Featured jobs
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
